ACTIVITY NUMBER:  RBP003

ACTIVITY TITLE: Adolescent Gynecology

ACCREDITATION STATEMENT

The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Release Date:  December 1, 2012

Reviewed and Updated: 2015, 2022, 2025

Expiration Date: March 31, 2029

Estimated Time to Complete Activity: 1.0 hour

NEEDS ASSESSMENT and IDENTIFICATION OF PRACTICE GAP

It is recommended that a woman’s initial visit to the obstetrician-gynecologist should occur between the ages of 13 and 15 years.  While gynecologic conditions that occur in adolescents are similar to those in adults, gynecologic care must be approached from multiple perspectives to comprehensively address the variations in psychological, social, sexual, and cognitive development of adolescent females.  In addition, clinicians must balance requirements for privacy and confidentiality while recognizing parents’ legitimate concerns for their child’s health and facilitating communication.  Not surprisingly, the demands have resulted in deficiencies in the provision of appropriate adolescent gynecologic care and services.   Fewer than 60% of resident physicians in obstetrics and gynecology felt their training in adolescent care was adequate or excellent, especially in areas of preventive counseling and general health services.¹

1.       Kershnar R, Hooper C, Gold M, Norwitz ER, Illuzzi JL. Adolescent medicine: attitudes, training, and experience of pediatric, family medicine, and obstetric-gynecology residents. Yale J Biol Med. 2009 Dec;82(4):129-41.

This educational activity is designed to address the Unit 5 Reproductive Endocrinology educational objectives from the Council on Resident Education in Obstetrics and Gynecology (CREOG) on this topic.

EDUCATIONAL OBJECTIVES

At the conclusion of the educational activity, participants should be able to:

1.       Discuss the gynecologic issues often experienced by adolescent women.

2.       Obtain a pertinent medical and sexual history from an adolescent patient.

3.       Describe a physical examination that includes special attention to the needs of an adolescent patient.

4.       Interpret selected tests to confirm the diagnosis of specific gynecologic disorders in an adolescent patient.

5.       Identify appropriate medical and surgical treatment for adolescent gynecologic disorders.

6.       Describe the indications for referral.

7.       Discuss the long-term prognosis of conditions on reproduction and sexual function.

TARGET AUDIENCE

This activity is designed to meet the educational needs of resident physicians in obstetrics and gynecology and other related specialties.

ACGME COMPETENCIES

Medical Knowledge

Patient Care

Interpersonal and Communication Skills

SUCCESSFUL COMPLETION REQUIREMENTS

Successful completion of this educational activity requires the learner to:

·         View a course overview page, containing all CME and disclosure information, including acknowledgement of commercial support and disclosure of unlabeled use, prior to the start of each module.

·         Complete a 10-question pre-exam prior to the module. Learners should note any pre-exam questions answered incorrectly for clarification during module study.  

·         Be given the option of downloading a printed syllabus containing the presentation and narrative.

·         Participate in the interactive activity: Audio narration is synchronized with PowerPoint presentation that can be advanced, stopped or reversed as desired.

·         Complete a 10-question post-exam, with feedback of correct/incorrect answers, scoring a minimum of 70% in two attempts.

·         Complete the evaluation survey.

·         Print certificate of completion.

DISCLOSURE STATEMENT

It is the policy of ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/speakers participating in this activity are required to disclose any relationships they may have with companies whose products or services could be mentioned, allowing participants to determine the objectivity of the presentations. The content and views presented in this activity are those of the faculty/speakers and do not necessarily reflect those of ASRM. Any discussion of the off-label, experimental, or investigational use of drugs or devices is not allowed. The disclosure statements were reviewed by the CME Subcommittee and the Executive Program Committee of ASRM, and any perceived conflicts of interest were resolved in accordance with the ACCME’s policies and Standards of Integrity and Independence in Accredited Continuing Education.  

PRIOR CONTRIBUTORS AND REVIEWERS  

Ruben J.  Alvero, MD – Nothing to Disclose  

Alicia Y. Armstrong, MD  – Nothing to Disclose  

Valerie Baker, MD  – Institutional Support from IBSA  

Nancy A. Bowers, BSN, RN, MPH  – Nothing to Disclose  

Bruce R. Carr, MD – Research support from Wyeth, Neurocrine, Boehringer Ingelheim; Consultant for Novo Nordisk   

Marcelle I. Cedars, MD  – Nothing to Disclose  

Marc Goldstein, MD – Advisory Board: Theralogix  

Elizabeth A. Grill, PsyD – Nothing to Disclose  

Andrew R. La Barbera, PhD, HCLD  – Nothing to Disclose  

Lawrence C. Layman, MD – Nothing to Disclose  

Meredith Loveless, MD – Nothing to Disclose  

Janet McLaren, MD – Nothing to Disclose  

Patricia M. McShane, MD – Nothing to Disclose  

Shona C. Murray, MD - Nothing to Disclose  

Steven T.  Nakajima, MD –Consultant, research support, speaker’s bureau for Warner Chilcott; Stockholder for IntegraMed  

Staci E. Pollack, MD – Nothing to Disclose  

Randal D. Robinson, MD - Speaker’s bureau for Merck and Teva  

Richard H. Reindollar, MD – Nothing to Disclose  

Nanette Santoro, MD – Consultant for QuatRx  

James H. Segars, MD – Nothing to Disclose  

Mary D. Stephenson, MD, MSc –  Consultant for NoraTherapeutics  

Kim L. Thornton, MD – Consultant for Parexel  

James P. Toner, M.D., Ph.D. -  Research support from Columbia Laboratories  

Mark Trolice, MD – Cryos International – Paid Consultant (Self); Alto Pharmacy – Direct Stockholder (Self)  

Ellen Wilson, MD – Nothing to Disclose  

Bo Yu, MD – Nothing to Disclose  

2025 CONTENT DEVELOPERS  

Heather Burks – Pacific Coast Reproductive Society – Board of Directors (Self)  

LaTasha Craig — Ferring Pharmaceuticals – Paid Consultant (Self)  

Rani Fritz, MD – Cradle Genomics – Medical Advisory Board (Self)  

Ryan Heitmann –  Nothing to Disclose  

Sarah Hmaidan – Nothing to Disclose  

Bradley S. Hurst, MD – Nothing to Disclose  

Patricia Jiminez, MD – Society for Reproductive Investigation – Member of DEI, Early Career, and CME committee*  

Molly Kornfield – Nothing to Disclose  

Dab Lebovic – Ferring Pharmaceutical – Paid Consultant (Self)  

Nora Miller, MD – Nothing to Disclose  

Ariya Mobaraki, MD – Nothing to Disclose  

Amalia Namath, MD – Nothing to Disclose  

Chioma Ogbejesi – Nothing to Disclose  

Pamela Parker, MD – Nothing to Disclose  

Jensen Reckhow, MD – Nothing to Disclose  

2025-2026 COURSE REVIEWERS (* beta-test participant reviewer; not responsible for content)  

Anisha Chada, MD – Nothing to Disclose*

Heather Hipp, MD – Nothing to Disclose  

Paul Lin, MD – Nothing to Disclose  

Pamela Parker, MD – Nothing to Disclose  

Divah Shah, MD – Nothing to Disclose  

Mark Trolice, MD – Cryos International – Paid Consultant (Self); Alto Pharmacy – Direct Stockholder (Self)  

David Walker – Nothing to Disclose  

ASRM STAFF PLANNERS AND DEVELOPERS  

Deidra Cain, DrPH, EdD – (former staff)  

Michelle Landrum, EdD – (former staff)  

Chevis Shannon, DrPH, MBA – Nothing to Disclose  

Harriet Smith, M.Ed - Nothing to Disclose  

STATEMENT OF SUPPORT  

No commercial support has been provided for this activity.   

It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors participating in this activity were required to disclose any relationships they may have with commercial entities whose products or services are used to treat patients so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM or CREOG. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.

STATEMENT OF SUPPORT

No commercial support has been provided for this activity.